Human gtp-binding proteins
CA 2274735 A1 · Owner: Hillman, Jennifer L. · Inventors: Bandman, Olga; Hillman, Jennifer L.; Goli, Surya K.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides three novel GTP-binding proteins (designated individually as BND-1, BND-2, and BND-3 and collectively as BND) and , polynucleotides which identify and encode BND. The invention also provides genetically engineered expression vectors and host cells comprising the nucleic acid sequences encoding BND and a method for producing BND. The invention also provides for use of BND and agonists antibodies, or , antagonists specifically binding BND in the prevention and treatment of , diseases associated with expression of BND. Additionally the invention , provides for the use of antisense molecules to polynucleotides encoding BND for the treatment of diseases …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 8, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 8, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 8, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.